HYPERTONIC FLUID ADMINISTRATION IN PATIENTS WITH SEPTIC SHOCK: A PROSPECTIVE RANDOMIZED CONTROLLED PILOT STUDY

被引:40
|
作者
van Haren, Frank M. P. [1 ]
Sleigh, James [2 ]
Boerma, E. Christiaan [3 ]
La Pine, Mary [2 ]
Bahr, Mohamed [2 ]
Pickkers, Peter [4 ]
van der Hoeven, Johannes G. [4 ]
机构
[1] Canberra Hosp, Dept Intens Care, Canberra, ACT, Australia
[2] Waikato Hosp, Dept Intens Care, Hamilton, New Zealand
[3] Med Ctr Leeuwarden, Dept Intens Care, Leeuwarden, Netherlands
[4] Radboud Univ Nijmegen, Med Ctr, Dept Intens Care, NL-6525 ED Nijmegen, Netherlands
来源
SHOCK | 2012年 / 37卷 / 03期
关键词
Hypertonic fluid; septic shock; hydroxyethyl starch; microcirculation; tonometry; IMPROVE CARDIAC-FUNCTION; HEMORRHAGIC-SHOCK; SALINE-DEXTRAN; VOLUME RESUSCITATION; BLOOD-FLOW; PERFUSION; MICROCIRCULATION; CONTRACTILITY; 7.5-PERCENT; MECHANISMS;
D O I
10.1097/SHK.0b013e31823f152f
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
We assessed the short-term effects of hypertonic fluid versus isotonic fluid administration in patients with septic shock. This was a double-blind, prospective randomized controlled trial in a 15-bed intensive care unit. Twenty-four patients with septic shock were randomized to receive 250 mL 7.2% NaCl/6% hydroxyethyl starch (HT group) or 500 mL 6% hydroxyethyl starch (IT group). Hemodynamic measurements included mean arterial blood pressure (MAP), central venous pressure, stroke volume index, stroke volume variation, intrathoracic blood volume index, gastric tonometry, and sublingual microcirculatory flow as assessed by sidestream dark field imaging. Systolic tissue Doppler imaging velocities of the medial mitral annulus were measured using echocardiography to assess left ventricular contractility. Log transformation of the ratio MAP divided by the norepinephrine infusion rate (log MAP/NE) quantified the combined effect on both parameters. Compared with the IT group, hypertonic solution treatment resulted in an improvement in log MAP/NE (P = 0.008), as well as an increase in systolic tissue Doppler imaging velocities (P = 0.03) and stroke volume index (P = 0.017). No differences between the groups were found for preload parameters (central venous pressure, stroke volume variation, intrathoracic blood volume index) or for afterload parameters (systemic vascular resistance index, MAP). Hypertonic solution treatment decreased the need for ongoing fluid resuscitation (P = 0.046). No differences between groups were observed regarding tonometry or the sublingual microvascular variables. In patients with septic shock, hypertonic fluid administration did not promote gastrointestinal mucosal perfusion or sublingual microcirculatory blood flow in comparison to isotonic fluid. Independent of changes in preload or afterload, hypertonic fluid administration improved the cardiac contractility and vascular tone compared with isotonic fluid. The need for ongoing fluid resuscitation was also reduced.
引用
收藏
页码:268 / 275
页数:8
相关论文
共 50 条
  • [21] Levosimendan for resuscitating the microcirculation in patients with septic shock: a randomized controlled study
    Morelli, Andrea
    Donati, Abele
    Ertmer, Christian
    Rehberg, Sebastian
    Lange, Matthias
    Orecchioni, Alessandra
    Cecchini, Valeria
    Landoni, Giovanni
    Pelaia, Paolo
    Pietropaoli, Paolo
    Van Aken, Hugo
    Teboul, Jean-Louis
    Ince, Can
    Westphal, Martin
    CRITICAL CARE, 2010, 14 (06):
  • [22] Extracorporeal cytokine adsorption in septic shock: A proof of concept randomized, controlled pilot study
    Hawchar, Fatime
    Laszlo, Ildiko
    Oveges, Nandor
    Trasy, Domonkos
    Ondrik, Zoltan
    Molnar, Zsolt
    JOURNAL OF CRITICAL CARE, 2019, 49 : 172 - 178
  • [23] Effects of thiamine on vasopressor requirements in patients with septic shock: a prospective randomized controlled trial
    Petsakul, Suttasinee
    Morakul, Sunthiti
    Tangsujaritvijit, Viratch
    Kunawut, Parinya
    Singhatas, Pongsasit
    Sanguanwit, Pitsucha
    BMC ANESTHESIOLOGY, 2020, 20 (01)
  • [24] Effects of thiamine on vasopressor requirements in patients with septic shock: a prospective randomized controlled trial
    Suttasinee Petsakul
    Sunthiti Morakul
    Viratch Tangsujaritvijit
    Parinya Kunawut
    Pongsasit Singhatas
    Pitsucha Sanguanwit
    BMC Anesthesiology, 20
  • [25] Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: a prospective randomized trial
    Loisa, Pekka
    Parviainen, Ilkka
    Tenhunen, Jyrki
    Hovilehto, Seppo
    Ruokonen, Esko
    CRITICAL CARE, 2007, 11 (01):
  • [26] Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: a prospective randomized trial
    Pekka Loisa
    Ilkka Parviainen
    Jyrki Tenhunen
    Seppo Hovilehto
    Esko Ruokonen
    Critical Care, 11
  • [27] Assessment of the components of fluid balance in patients with septic shock: a prospective observational study
    de Souza, Maria Aparecida
    Ramos, Fernando Jose da Silva
    Svicero, Bianca Silva
    Nunes, Nathaly Fonseca
    Cunha, Rodrigo Camillo
    Machado, Flavia Ribeiro
    de Freitas, Flavio Geraldo Rezende
    BRAZILIAN JOURNAL OF ANESTHESIOLOGY, 2024, 74 (02):
  • [28] EFFECTS OF CORTICOSTEROIDS IN SEPTIC SHOCK - A PROSPECTIVE, RANDOMIZED STUDY
    SPRUNG, CL
    CARALIS, PV
    PIERCE, M
    MARCIAL, EH
    KARPF, M
    CLINICAL RESEARCH, 1983, 31 (02): : A260 - A260
  • [29] The Interaction of Vasopressin and Corticosteroids in Septic Shock: A Pilot Randomized Controlled Trial
    Gordon, Anthony C.
    Mason, Alexina J.
    Perkins, Gavin D.
    Stotz, Martin
    Terblanche, Marius
    Ashby, Deborah
    Brett, Stephen J.
    CRITICAL CARE MEDICINE, 2014, 42 (06) : 1325 - 1333
  • [30] The Restrictive IV Fluid Trial in Severe Sepsis and Septic Shock (RIFTS): A Randomized Pilot Study
    Corl, Keith A.
    Prodromou, Michael
    Merchant, Roland C.
    Gareen, Ilana
    Marks, Sarah
    Banerjee, Debasree
    Amass, Timothy
    Abbasi, Adeel
    Delcompare, Cesar
    Palmisciano, Amy
    Aliotta, Jason
    Jay, Gregory
    Levy, Mitchell M.
    CRITICAL CARE MEDICINE, 2019, 47 (07) : 951 - 959